Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

16. April 2026 09:15 ET | Quelle: Myriad Genetics, Inc.

Myriad Genetics to Deliver Six Abstracts, Including Two Podiums, at AACR 2026

Myriad Genetics will share six abstracts, including two podium presentations, at the American Association for Cancer Research (AACR) Annual Meeting.
09. April 2026 09:15 ET | Quelle: Myriad Genetics, Inc.

Myriad Genetics Underscores Commitment to Cancer Care Continuum with New Data Presentations at SGO Annual Meeting

Myriad will share new data at the Society of Gynecologic Oncology (SGO) Annual Meeting April 10-13, including two oral presentations and two posters.
01. April 2026 08:00 ET | Quelle: Alignment Healthcare USA, LLC

Alignment Healthcare to Present at the BofA Securities Health Care Conference 2026

ORANGE, Calif., April 01, 2026 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), today announced that it will present at the BofA Securities Health Care Conference 2026 in Las Vegas on...
10. März 2026 07:00 ET | Quelle: Rapport Therapeutics, Inc.

Rapport Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Rapport Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
03. März 2026 16:05 ET | Quelle: Fate Therapeutics, Inc.

Fate Therapeutics to Participate in Leerink Partners 2026 Global Healthcare Conference

SAN DIEGO, March 03, 2026 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced...
24. Februar 2026 16:05 ET | Quelle: UroGen Pharma Ltd.

UroGen Pharma to Present at the TD Cowen 46th Annual Health Care Conference

PRINCETON, N.J., Feb. 24, 2026 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and...
23. Februar 2026 08:00 ET | Quelle: Alignment Healthcare USA, LLC

Alignment Healthcare to Present at the Leerink Partners Global Healthcare Conference

ORANGE, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), today announced that it will present at the Leerink Partners Global Healthcare Conference in Miami,...
05. Februar 2026 16:05 ET | Quelle: Surrozen, Inc.

Surrozen to Present at Upcoming Healthcare Investor Conference

Surrozen to Present at Upcoming Healthcare Investor Conference
12. Januar 2026 09:15 ET | Quelle: Processa Pharmaceuticals, Inc.

Processa Pharmaceuticals to Attend 44th Annual J.P. Morgan Healthcare Conference

VERO BEACH, Fla., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA), a clinical-stage biopharmaceutical company developing Next Generation Cancer (NGC) therapies, today...
12. Januar 2026 08:30 ET | Quelle: Myriad Genetics, Inc.

Myriad Genetics Announces Select Preliminary Fourth Quarter and Full Year 2025 Financial Results and Introduces Full Year 2026 Financial Guidance

Myriad announced select unaudited preliminary results for the 4th quarter and full year ended Dec. 31, 2025, provided full year 2026 financial guidance.

Nächste Seite